Amikacin-Fosfomycin at a Five-to-Two Ratio: Characterization of Mutation Rates in Microbial Strains Causing Ventilator-Associated Pneumonia and Interactions with Commonly Used Antibiotics

類似資料

• Potentiation Effects of Amikacin and Fosfomycin against Selected Amikacin-Nonsusceptible Gram-Negative Respiratory Tract Pathogens
  著者:: Montgomery, A. Bruce, 等
  出版事項: (2014)
• The win ratio method: a novel hierarchical endpoint for pneumonia trials in patients on mechanical ventilation
  著者:: Montgomery, A, 等
  出版事項: (2014)
• A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow(®) Inline Nebulizer System in Mechanically Ventilated Patients
  著者:: Montgomery, A. Bruce, 等
  出版事項: (2014)
• Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy
  著者:: Sime, Fekade Bruck, 等
  出版事項: (2016)
• The effect of administration of fosfomycin in the management of ventilator-associated pneumonia
  著者:: Shaimaa S Mohamed, 等
  出版事項: (2018-01-01)